Myriam Mirza (PhD, MBA) is an associate principal in the Life Sciences Practice and has over eight years of consulting experience across the US, Europe, and APAC markets.
She has worked with small to medium-sized enterprises, large pharmaceutical companies, and medical device companies on market access, medical affairs, and commercial strategy opportunities. Her expertise lies with opportunity and pipeline assessment, market entry and expansion strategies, market research, and stakeholder engagement.
Myriam has experience across a range of different therapeutic areas, having worked with clinical experts, patient advocacy groups, and national decision-makers in CNS, immunology, metabolic, rare disease, and oncology-based indications.
Prior to joining CRA, Myriam worked as a freelance healthcare and nonprofit consultant, working closely with patient and caregiver-led foundations to implement rare disease clinical programs and consulting to European and US clients on commercial strategies. She has presented at board meetings, international conferences, and has been invited as a rare disease keynote speaker on numerous occasions.
Myriam is co-chair of the Parents and Caregivers Employee Resource Group at CRA (PAC@CRA).